MAB4617

Anti-Survivin Antibody, clone 8E2

Name: Anti-Survivin Antibody, clone 8E2
Brand: MM

clone 8E2, Chemicon^®, from mouse

Synonym(s):

TIAP

Select a Size

All Photos(1)

About This Item

UNSPSC Code:

12352203

NACRES:

NA.41

eCl@ss:

32160702

Product Name

Anti-Survivin Antibody, clone 8E2, clone 8E2, Chemicon^®, from mouse

biological source

mouse

conjugate

unconjugated

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

8E2, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon^®

technique(s)

ELISA: suitable
immunofluorescence: suitable

isotype

IgG1

suitability

not suitable for Western blot

NCBI accession no.

NM_001012270.1
NM_001012271.1
NM_001168.2

UniProt accession no.

O15392

shipped in

wet ice

target post-translational modification

unmodified

Gene Information

human ... BIRC5(332)

Application

Detect Survivin using this Anti-Survivin Antibody, clone 8E2 validated for use in ELISA & IF.

Immunofluorescence

ELISA (for detection only)

Does not work for Western Blot

Does not work for Immunohistochemistry

Optimal working dilutions must be determined by end user.

Research Category
Apoptosis & Cancer

Research Sub Category
BCL2 & Inhibition

Biochem/physiol Actions

MAB4617 detects human survivin (16.5 kDa).

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

Survivin, an inhibitor of apoptosis (IAP) protein, is expressed in the G2/M phase of the cell cycle in a cycle-regulated manner. At the beginning of mitosis, survivin associates with microtubules of the mitotic spindle in a specific and saturable reaction that is regulated by microtubule dynamics. Disruption of survivin-microtubule interactions results in loss of survivin′s anti-apoptosis function and increased caspase-3 activity, a mechanism involved in cell death, during mitosis. It indicates that survivin may counteract a default induction of apoptosis in G2/M phase. The overexpression of survivin in cancer may overcome this apoptotic checkpoint and favor aberrant progression of transformed cells through mitosis.

Immunogen

Full length recombinant human survivin

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Replaces: MAB3509

Physical form

Format: Purified

Purified immunoglobulin, by Protein G. Liquid in 10 mM PBS, pH 7,4 containing 0.2% BSA and 0.09% sodium azide.

Preparation Note

Maintain at 2-8°C for up to 12 months.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Not finding the right product?

Try our Product Selector Tool.

Storage Class

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Gemcitabine combined with an engineered oncolytic vaccinia virus exhibits a synergistic suppressive effect on the tumor growth of pancreatic cancer.

Wanyuan Chen et al.

Oncology reports, 41(1), 67-76 (2018-10-27)

Pancreatic cancer (PC) is a lethal solid malignancy with resistance to traditional chemotherapy. Recently, considerable studies have demonstrated the ubiquitous antitumor properties of gene therapy mediated by the oncolytic vaccinia virus. The second mitochondrial‑derived activator of caspase (Smac) has been